Form: 6-K

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

May 28, 2021

Exhibit 99.1

 

MIND MEDICINE (MINDMED) INC.

(the “Corporation”)

 

ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

REPORT OF VOTING RESULTS

 

Pursuant to Section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations

 

The following briefly describes the matters voted upon and the outcome of votes at the annual and special meeting of shareholders the Corporation held on Thursday, May 27, 2021 (the “Meeting”).

 

At the Meeting, holders of the subordinate voting shares in the capital of the Corporation (the “Subordinate Voting Shares”) and the multiple voting shares in the capital of the Corporation (the “Multiple Voting Shares”, and together with the Subordinate Voting Shares, the “Shares”) voted together as a single class. Holders of Subordinate Voting Shares are entitled to one vote in respect of each Subordinate Voting Share, and holders of Multiple Voting Shares are entitled to one hundred votes in respect of each Multiple Voting Share. The below reflects the votes cast in respect of the Subordinate Voting Shares and the Multiple Voting Shares, voting together as a single class.

 

(a) Fixing the Number of Directors

 

By a vote conducted by way of an electronic ballot, the number of directors was fixed to seven. The Shares were voted as follows:

 

    Votes For   % For   Votes Against   % Against
                 
Fixing the Number of Directors to Seven   91,392,785   92.86%   7,031,000   7.14%

 

(b) Election of Directors

 

By a vote conducted by way of an electronic ballot, the seven (7) nominees proposed as directors were elected to hold office until the next annual meeting of shareholders or until his or her successor is duly elected or appointed. The Shares were voted as follows:

 

    Votes For   % For   Votes Withheld   % Withheld
                 
Sarah Vinson   92,630,397   100%   0   0%
Jamon Alexander Rahn   93,558,511   95.01%   4,917,031   4.99%
Miriam Halperin Wernli   93,716,219   95.17%   4,759,323   4.83%
Stephen Hurst   92,630,397   94.06%   5,845,145   5.94%
Bruce Linton   94,640,504   96.11%   3,835,038   3.89%
Perry Dellelce   93,265,188   94.71%   5,210,354   5.29%
Brigid Makes   94,679,281   96.14%   3,796,261   3.86%

 

 

 

 

(c) Appointment of Auditor

 

By a vote conducted by way of an electronic ballot, RSM Canada LLP were re-appointed as auditors of the Corporation to hold office until the close of business of the next annual meeting of shareholders, and the board of directors of the Corporation was authorized to fix their remuneration (the “Auditor Resolution”). The Shares were voted as follows:

 

    Votes For   % For   Votes Withheld   % Withheld
                 
Auditor Resolution   157,088,949   97.63%   3,820,105   2.37%

 

 

(d) Amendment to Articles

 

By a vote conducted by way of an electronic ballot, the resolution authorizing the Corporation to amend and restate the articles of the Corporation (the “Alteration Resolution”), as more particularly described in the management information circular of the Corporation dated April 19, 2021 (the “Circular”), was passed. The Shares were voted as follows:

 

    Votes For   % For   Votes Against   % Against
                 
Alteration Resolution   96,530,321   98.02%   1,945,221   1.98%

 

 

(e) Reservation of Shares

 

By a vote conducted by way of an electronic ballot, the resolution approving the increase in the number of Subordinate Voting Shares reserved under the Corporation’s share option plan and its performance share unit and restricted share unit compensation plan (the “Compensation Plans Increase Resolution”), as more particularly described in the Circular, was passed. The Shares were voted as follows:

 

    Votes For   % For   Votes Against   % Against
                 
Compensation Plans Increase Resolution   15,223,285   68.16%   7,112,884   31.84%

 

 

 

Dated: May 28, 2021.

 

 

  MIND MEDICINE (MINDMED) INC.  
     
     
   (signed) “David Guebert  
  David Guebert  
  Chief Financial Officer